A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
Active, not recruiting · NCT05849298 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-09-11 | NCT05849298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Houston Methodist Hospital | Houston | United States | 260 |
| Oregon Urology Institute | Springfield | United States | 14 |
| Rio Grande Urology | El Paso | United States | 5 |
| Rocky Mountain Cancer Centers | Denver | United States | 26 |
| Unity Point Clinic | Des Moines | United States | 2 |
| Univ of Texas Southwest Med Center | Dallas | United States | 6 |
| University Cancer and Blood Center LLC | Athens | United States | 49 |
| Urology Cancer Center PC | Omaha | United States | 8 |
| Urology Of Indiana | Indianapolis | United States | 1 |
| WellSpan York Hospital | York | United States | 14 |